NEW YORK, Aug. 30, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been
filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to
request that the court appoint you as lead plaintiff.
Facebook, Inc. (NASDAQ: FB)
Class Period: October 1, 2017 to July 26, 2018
Lead Plaintiff Deadline: September 25, 2018
The lawsuit alleges that Facebook, Inc. made materially false and/or misleading statements and/or failed to
disclose that: (i) the implementation of the General Data Protection Regulation (“GDPR”), which was adopted by the European Union
on or around April 14, 2016, would have a foreseeable and materially negative impact on use of the Platform, revenue growth, and
profitability because the informed consent required by the GDPR resulted in many users rejecting Facebook’s privacy policies and/or
procedures and exposed a significant number of fake accounts on the platform; (ii) by May 25, 2018, Facebook’s Platform use and
revenue growth had already begun to decline as a result of Facebook’s efforts to comply with the GDPR; (iii) the decline in
Facebook’s Platform use and the increase in costs as a result of complying with the GDPR had a materially adverse effect on
Facebook’s financial health, including its revenue and projected growth; and (iv) as a result, Facebook’s public statements were
materially false and misleading at all relevant times.
Get additional information about the FB lawsuit: http://www.kleinstocklaw.com/pslra-c/facebook-inc-3?wire=3
Sinclair Broadcast Group, Inc. (NASDAQ: SBGI)
Class Period: February 22, 2017 to July 19, 2018
Lead Plaintiff Deadline: October 9, 2018
According to the complaint, Sinclair Broadcast Group, Inc. allegedly made materially false and/or misleading
statements and/or failed to disclose that: (i) the merger of Tribune Media Company (NYSE: TRCO) and Sinclair was not in compliance
with FCC rules and regulations; (ii) Sinclair was not using its best efforts to eliminate any impediment to regulatory approval;
(iii) Sinclair was engaging in non-arm’s length transactions with buyers connected to Sinclair’s controlling shareholders in order
to skirt FCC ownership rules; and (iv) that, as a result of the foregoing, Defendant’s public statements were materially false
and/or misleading and/or lacked a reasonable basis.
On May 8, 2017, Sinclair announced it had entered into an agreement to acquire 100% of the issued outstanding
shares of Tribune. On August 3, 2017, Sinclair filed a Form 8-K with the U.S. Securities and Exchange Commission disclosing that
the U.S. Department of Justice had requested additional information and documentary material pertaining to the agreement. Then on
August 9, 2018, Tribune said it had terminated the deal and was suing Sinclair for breach of contract following the FCC’s
determination that Sinclair failed to fully disclose material information about the merger.
Get additional information about the SBGI lawsuit: http://www.kleinstocklaw.com/pslra-c/sinclair-broadcast-group-inc?wire=3
Tesla, Inc. (NASDAQ: TSLA)
Class Period: Purchasers of shares between August 7, 2018 and August 17, 2018 and/or who had open short positions or put options
for Tesla as of August 7, 2018 or August 8, 2018
Lead Plaintiff Deadline: October 9, 2018
The lawsuit alleges that throughout the class period, Tesla, Inc. made materially false and/or misleading
statements and/or failed to disclose that: (1) that the Defendants had not secured funding for the Going-Private Transaction; (2)
that Musk’s statements that the Going-Private Transaction only required shareholder approval were false since the Going-Private
Transaction required approval by the Company’s Board of Directors and even the Board was unaware of the funding referred to by
Musk; (3) that the status and likelihood of the Going-Private Transaction was misrepresented to the market because financing for it
had not been secured and Board approval was required, and (4) as a result of the foregoing, Defendants’ statements about Tesla’s
business, operations, and prospects, were materially false and/or misleading and/or lacked a reasonable basis.
Get additional information about the TSLA lawsuit: http://www.kleinstocklaw.com/pslra-1/tesla-inc-submission-form?wire=3
Ampio Pharmaceuticals, Inc. (NYSEAmerican: AMPE)
Class Period: December 14, 2017 to August 7, 2018
Lead Plaintiff Deadline: October 24, 2018
According to the complaint, Ampio Pharmaceuticals, Inc. allegedly made materially false and/or misleading
statements and/or failed to disclose that: (1) the FDA would find Ampio's AP-003-C Phase 3 clinical trial inadequate and not
well-controlled; (2) as a result, Ampio had not successfully completed two pivotal clinical trials for Ampio; (3) consequently,
Defendants' public statements were materially false and misleading at all relevant times.
Get additional information about the AMPE lawsuit: http://www.kleinstocklaw.com/pslra-1/ampio-pharmaceuticals-inc-loss-form?wire=3
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or
obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph
Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud
throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
